elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40880167-951F430C-B4A9-4ACA-9A69-96F4CCCD9F97
Q40880167-951F430C-B4A9-4ACA-9A69-96F4CCCD9F97
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40880167-951F430C-B4A9-4ACA-9A69-96F4CCCD9F97
Incorporating future costs in medical cost-effectiveness analysis: implications for the cost-effectiveness of the treatment of hypertension.
P2860
Q40880167-951F430C-B4A9-4ACA-9A69-96F4CCCD9F97
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40880167-951F430C-B4A9-4ACA-9A69-96F4CCCD9F97
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8d1b334c6bb28b817685480f9c79b53d3774c5d6
P2860
Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?